A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients using ColoPrint

Diseases and Conditions Researched

Colon Cancer


Participation Guidelines

Age: 18 Years and older
Gender: Both

Click here for detailed participation information for this trial.

Sponsor: Onconova Therapeutics, Inc.
Study HIC#: 1104008300